Advanced Metastatic Breast Cancer Clinical Trials

ReadTheTrial indexes 2 studies for Advanced Metastatic Breast Cancer. The most common development stage is Phase 3 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Advanced Metastatic Breast Cancer.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 1
50%
N/A 1
50%

Trial Status Breakdown

Trials for Advanced Metastatic Breast Cancer

A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase III Study to Evaluate the Efficacy and Safety of Letrozole SIE Compared to Femara® (Both in Combination With the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women With HR-Positive, HER2-Negative, Inoperable Locally Advanced or Metastatic Breast Cancer (SIE-3)

NCT07340658 · NOT YET RECRUITING · Phase 3

A Pilot Study on the Analysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer

NCT06706557 · RECRUITING · N/A

Frequently Asked Questions

What clinical trials are available for Advanced Metastatic Breast Cancer?

There are 2 clinical trials listed for Advanced Metastatic Breast Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Advanced Metastatic Breast Cancer trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Advanced Metastatic Breast Cancer trials in?

Current Advanced Metastatic Breast Cancer trials are distributed across: Phase 3 (1), N/A (1).

Find More Trials